GrantRover ↗

← Alle Förderungen

Defense Health Agency Contracting Activity - DHACA · USA

DoW Breast Cancer, Clinical Research Extension Award

Offen

Defense Health Agency Contracting Activity - DHACA plant 1 Förderungen bei einem Gesamtbudget von 8,4 Mio. $. Die Einreichungsfrist endet am 18. November 2026. Antragsberechtigte Gruppen laut Quelle: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility".

Frist
18. November 2026 (in 3 Tagen)
Fördersumme
8,4 Mio. $ (eine Förderung)
Förderquote
Kein Pflicht-Eigenanteil angegeben; Förderquote nicht angegeben
Gesamtbudget
8,4 Mio. $
Erwartete Förderungen
1
Eigenanteil
Nicht erforderlich
Wahrscheinliche Antragstellende
Unternehmen, KMU / Start-ups, Gemeinnützige, Hochschulen & Forschung, Öffentliche Stellen, Einzelpersonen Aus Quellkategorien oder Programmregeln; maßgeblich ist die Ausschreibung.
Fördergeber
Defense Health Agency Contracting Activity - DHACA
Referenz
HT942526BCRPCREA2
Assistance Listing (USA)
12.420 Military Medical Research and Development
Zuletzt geprüft
13. November 2026

Offizielle Ausschreibung öffnen ↗ Frist zum Kalender hinzufügen

Die offiziellen Beschreibungen sind in der Sprache des Fördergebers (meist Englisch); Zusammenfassung und Eckdaten auf dieser Seite sind auf Deutsch.

Über diese Ausschreibung

Summary: The fiscal year 2026 (FY26) Breast Cancer Research Program (BCRP) Clinical Research Extension Award supports research that extends the data collection, follow-up, and analysis of breast cancer clinical studies. The intent of this award mechanism is to increase the clinically relevant impact of breast cancer patient participation in clinical studies by addressing the knowledge lost due to early trial termination, limited patient follow-up, or suboptimal sample and/or data collection and analysis. All applications must address at least one of the FY26 BCRP overarching challenges or provide adequate justification for exception.

Distinctive Features:

• The research team must include two or more breast cancer consumer advocates.

• This funding mechanism allows for a single Principal Investigator (PI), or two partnering PIs referred to as the Initiating PI and the Partnering PI. For the Partnering PI Option (PPIO), only the Initiating PI will submit a pre-application, but both PIs will need to submit at the full application stage. Be advised, failure to submit all associated (Initiating and Partnering PI) applications by the deadline may result in administrative withdrawal.

Wer kann sich bewerben?

Antragstellerkategorien sind nur ein Ausgangspunkt. Über die Antragsberechtigung entscheidet die offizielle Ausschreibung.

Themen

Science and Technology and other Research and Development

So bewerben Sie sich

  1. Read the full notice of funding opportunity (NOFO) linked from the official page: eligibility, cost sharing and evaluation criteria.
  2. Make sure your organisation has an active SAM.gov registration and Unique Entity ID (UEI); registration can take several weeks.
  3. Register with Grants.gov and set up a Workspace for this opportunity, with the right roles for your organisation.
  4. Prepare the required forms, narrative, budget and attachments exactly as the NOFO specifies.
  5. Submit before the deadline and keep the tracking number. Check for amendments before you submit.

From the call text

Who can apply
Not stated in the call text we hold — check the official page
Company stage
Not stated in the call text we hold — check the official page
Single applicant or consortium
Not stated in the call text we hold — check the official page
Where applicants must be based
Not stated in the call text we hold — check the official page
Where to apply
Not stated in the call text we hold — check the official page

Kontakt

Danielle Reckley · help@eBRAP.org · 301-619-1139

Offizielle Quellen

Offizielle Ausschreibungsseite

Die Angaben auf dieser Seite stammen aus der offiziellen Quelle und wurden zuletzt am 13. November 2026 geprüft. Maßgeblich sind immer die Unterlagen des Fördergebers einschließlich späterer Änderungen.

Weitere Ausschreibungen: Defense Health Agency Contracting Activity - DHACA

Defense Health Agency Contracting Activity - DHACA USA

DoW Joint Warfighter Medical, Military Medical Research and Development Award

HT942526JWMRPMMRDA

Summary: The fiscal year 2026 (FY26) Joint Warfighter Medical Research Program (JWMRP) Military Medical Research and Development Award (MMRDA) mechanism is intended to fu…

Defense Health Agency Contracting Activity - DHACA USA

DoW Breast Cancer, Breakthrough Award Levels 1 and 2

HT942526BCRPBTA122

Summary: The fiscal year 2026 (FY26) Breast Cancer Research Program (BCRP) Breakthrough Award mechanism supports promising research with high potential to lead to or make…

Defense Health Agency Contracting Activity - DHACA USA

DOW Combat Readiness – Medical Research Program Translational Research Award

HT942526CRRPTRA

Summary: The fiscal year 2026 (FY26) Combat Readiness – Medical Research Program (CRRP) Translational Research Award (TRA) supports hypothesis-driven innovative, high-imp…

Defense Health Agency Contracting Activity - DHACA USA

DoW Orthopaedic, Applied Research Award

HT942526ORPARA

Summary: The Orthopaedic Research Program (ORP) Applied Research Award (ARA) seeks applied research applications focused on advancing optimal treatment and restoration of…

Defense Health Agency Contracting Activity - DHACA USA

DoW Orthopaedic, Clinical Research Award

HT942526ORPCRA

Summary: The fiscal year 2026 (FY26) Orthopaedic Research Program (ORP) Clinical Research Award (CRA) seeks clinical research that evaluates orthopaedic-specific factors …